GET IN TOUCH
Seisa Medical Announces Acquisition of Burpee MedSystems
EL PASO, Texas--(BUSINESS WIRE)--Seisa Medical Inc., a full-service provider of integrated manufacturing and development services to the medical device industry, today announced that it has acquired Burpee MedSystems LLC, a leading manufacturer of stents and delivery devices.
“This acquisition demonstrates Seisa’s commitment to investing in vertical capabilities to create end-to-end solutions that deliver value to our customers,” said Julio Chiu, founder and CEO of Seisa Medical.
“The marriage between Seisa’s high-volume production of FDA Class II and Class III devices with Burpee MedSystems’ mastery in the manufacture of complex stents, delivery systems, and components will provide a scalable one-stop-shop for customers focused on the high-growth markets for implantable stents and their delivery systems.”
Janet Burpee, CEO and co-founder of New Jersey-based Burpee MedSystems added, “We are thrilled to be joining Seisa as it gives Burpee MedSystems the global infrastructure we’ve been aiming for to expand our offerings and capabilities to the market.” Janet and Steve Burpee will continue supporting the Burpee team and retain majority ownership of Tinker Med, LLC – a medical device incubator and holding company previously wholly owned by Burpee MedSystems. Seisa funded the transaction through its $52 million senior secured credit facility with Sagard Credit Partners. Seisa continues to actively pursue prudent and accretive acquisitions that add capability and geographic scope to the Texas-based company. “We are excited to welcome the Burpee team to Seisa,” said Chiu. “Together we offer not only a compelling offering for strategic outsourcing solutions in the medical device market, but also provide all our employees more opportunities globally as well.”
About Seisa Medical Inc:
Seisa Medical is a global full-service medical device manufacturer with more than three decades of experience and a Regulatory-focused culture (FDA-registered, ISO-certified). Seisa partners with leading medical device companies on projects ranging from concept to production and product evolution of FDA Class II and III devices. With multiple facilities in North America and Europe, Seisa’s more than 2,000 employees provide tailored solutions in molding, extrusion, device assembly, production scaling and packaging.